Melanoma journal articles for July/August 2016

Coffee consumption and the risk of malignant melanoma in the Norwegian Women and Cancer (NOWAC) Study

Marko Lukic, Mie Jareid, Elisabete Weiderpass and Tonje Braaten

BMC Cancer201616:562

DOI: 10.1186/s12885-016-2586-5

Received: 11 April 2016

Accepted: 20 July 2016

Published: 29 July 2016

The inhibitory effect of 7, 7”-dimethoxyagastisflavone on the metastasis of melanoma cells via the suppression of F-actin polymerization

DOI: 10.18632/oncotarget.10960

Ching-Min Lin^1,*, Yu-Ling Lin^2,3,*, Shu-Yi Ho³, Pin-Rong Chen¹, Yi-Hsuan Tsai¹, Chen-Han Chung¹, Chia-Hsiang Hwang⁴, Nu-Man Tsai^5,6,*, Shey-Cherng Tzou^1,3, Chun-Yen Ke¹, Jung Chang³, Yi-Lin Chan⁷, Yu-Shan Wang⁸, Kwan-Hwa Chi^8,*, Kuang-Wen Liao¹

ADAMTSL5 is upregulated in melanoma tissues in patients with idiopathic psoriasis vulgaris induced by nivolumab

Y. Nonomura, A. Otsuka, M. Ohtsuka, T. Yamamoto, R. Dummer, K. Kabashima

First published:27 July 2016Full publication history
DOI:1111/jdv.13818View/save citation

Complete regression of primary cutaneous malignant melanoma associated with distant lymph node metastasis: a teaching case mimicking blue nevus

Sohsuke Yamada, Aya Nawata, Manabu Yoshioka, Tsubasa Hiraki, Michiyo Higashi, Kazuhito Hatanaka and Akihide Tanimoto

BMC Research Notes20169:366

DOI: 10.1186/s13104-016-2174-4

Received: 13 April 2016

Accepted: 21 July 2016

Published: 26 July 2016

Fast diagnostics of BRAF mutations in biopsies from malignant melanoma

Francois Huber, Hans Peter Lang, Katharina Glatz, Donata Rimoldi, Ernst Meyer, and Christoph Gerber

Nano Lett., Just Accepted Manuscript

DOI: 10.1021/acs.nanolett.6b01513

Publication Date (Web): August 4, 2016

PD-1 Antibody Monotherapy for Malignant Melanoma: A Systematic Review and Meta-Analysis

Zhijuan Lin, Xing Chen, Zhifeng Li, Yiming Luo, Zhihong Fang, Bing Xu, Mingzhe Han

Published: August 2, 2016

http://dx.doi.org/10.1371/journal.pone.0160485

miR-579-3p controls melanoma progression and resistance to target therapy

Luigi Fattore ^a,¹, Rita Mancini ^b,¹, Mario Acunzo ^c, Giulia Romano ^c, Alessandro Laganà ^d,Maria Elena isanu ^e, Debora Malpicci ^e, Gabriele Madonna ^a, Domenico Mallardo ^a, Marilena Capone ^a,Franco Fulciniti ^f, Luca Mazzucchelli ^f, Gerardo Botti ^a, Carlo M. Croce ^c,², Paolo Antonio Ascierto ^a, and

Gennaro Ciliberto

doi: 10.1073/pnas.1607753113

Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model

Mako Yamamoto, Ming Zhao, Yukihiko Hiroshima, Yong Zhang, Elizabeth Shurell, Fritz C. Eilber, Michael Bouvet, Makoto Noda, Robert M. Hoffman

Published: August 8, 2016
http://dx.doi.org/10.1371/journal.pone.0160882

Anorectal melanoma metastatic to the breast: a case report and review of the literature

Authors Feng L, Qi DJ, Zhang QF

Received 26 February 2016

Accepted for publication 2 July 2016

Published 10 August 2016 Volume 2016:9 Pages 4969—4974

DOI https://dx.doi.org/10.2147/OTT.S107271

Synergic therapy of melanoma using GNRs-MUA-PEI/siIDO2-FA through targeted gene silencing and plasmonic photothermia

Yujuan Zhang, Na Song, Jiamin Fu, Yanling Liu, Xuelin Zhan, Shanshan Peng, Zhi Yang, Xianfang Zhu, Thomas E Ichim, Yiguo Chen, Zhigang Wang, Yanrong Yu, Xiaofa Shi, Yingyuan Fu, Ken Yuan, Nanjin Zhou and Weiping Min

RSC Adv., 2016, Accepted Manuscript
DOI: 10.1039/C6RA13297A
Received 23 May 2016, Accepted 13 Jul 2016
First published online 11 Aug 2016

BioRxiv

Recurrent promoter mutations in melanoma are defined by an extended context-specific mutational signature

Johan Fredriksson, Erik Larsson

doi: http://dx.doi.org/10.1101/069351

A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib

Maleka, . Åström, P. Byström and G. J. Ullenhag

BMC Cancer201616:634

DOI: 10.1186/s12885-016-2657-7

Received: 27 October 2015

Accepted: 1 August 2016

Published: 12 August 2016

Genetic Variants of the BTNL2 Gene in Uveal Melanoma ONLINE FIRST

Sarah E. Coupland, MBBS, PhD, FRCPath¹; Yamini Krishna, MBChB, PhD, FRCOphth¹

JAMA Ophthalmol. Published online August 11, 2016. doi:10.1001/jamaophthalmol.2016.2940

Melanoma differentiation associated gene 7/IL-24 exerts cytotoxic effects by altering the alternative splicing of Bcl-x pre-mRNA via the SRC/PKC? signaling axis.

Brian A. Shapiro 1, Ngoc T. Vu 1, Michael D. Shultz 2, Jacqueline C. Shultz 1, Jennifer A. Mietla 1, Mazen M. Gouda 1, Adly Yacoub 1, Paul Dent 1, Paul B. Fisher 1, Margaret A. Park 1 and Charles E. Chalfant

First Published onAugust 12, 2016doi: 10.1074/jbc.M116.737569jbc.M116.737569.

Lymphatic vessels regulate immune microenvironments in human and murine melanoma

Amanda W. Lund,^1,2 Marek Wagner,^3,4 Manuel Fankhauser,² Eli S. Steinskog,³ Maria A. Broggi,² Stefani Spranger,⁵ Thomas F. Gajewski,^5,6 Kari Alitalo,⁷ Hans P. Eikesdal,^8,9 Helge Wiig,³ and Melody A. Swartz^2,10

J Clin Invest. doi:10.1172/JCI79434.
Copyright © 2016, The American Society for Clinical Investigation.

Published August 15, 2016
Received: October 14, 2014 ; Accepted: July 7, 2016

Cancer

The efficacy of anti-PD-1 agents in acral and mucosal melanoma

Alexander N. Shoushtari MD, Rodrigo R. Munhoz MD, Deborah Kuk MS, Patrick A. Ott MD, PhD, Douglas B. Johnson MD, Katy K. Tsai MD, Suthee Rapisuwon MD, Zeynep Eroglu MD, Ryan J. Sullivan MD, Jason J. Luke MD, Tara C. Gangadhar MD, April K. S. Salama MD, Varina Clark BA, Clare Burias BA, Igor Puzanov MD, Michael B. Atkins MD, Alain P. Algazi MD, Antoni Ribas MD, PhD, Jedd D. Wolchok MD, PhD, Michael A. Postow MD

First published:17 August 2016
DOI:1002/cncr.30259

Cancer

Disparate clinical activity of PD-1 blockade in melanoma subtypes: Know thy enemy!

Authors

Shailender Bhatia MD, Kim Margolin MD

First published:17 August 2016
DOI:1002/cncr.30260
Cited by:0 articles

Cancer

Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-1L antibodies

Authors

Alain P. Algazi MD, Katy K. Tsai MD, Alexander N. Shoushtari MD, Rodrigo R. Munhoz MD, Zeynep Eroglu MD, Josep M. Piulats MD, PhD, Patrick A. Ott MD, PhD, Douglas B. Johnson MD, Jimmy Hwang PhD, Adil I. Daud MD, Jeffrey A. Sosman MD, Richard D. Carvajal MD, Bartosz Chmielowski MD, Michael A. Postow MD, Jeffrey S. Weber MD, PhD, Ryan J. Sullivan MD

First published:17 August 2016
DOI:1002/cncr.30258
Cited by:0 articles

Shani Dror, Laureen Sander, Hila Schwartz, Danna Sheinboim, Aviv Barzilai, Yuval Dishon, Sebastien Apcher, Tamar Golan, Shoshana Greenberger, Iris Barshack, Hagar Malcov, Alona Zilberberg, Lotan Levin, Michelle Nessling, Yael Friedmann, Vivien Igras, Ohad Barzilay, Hananya Vaknine, Ronen Brenner, Assaf Zinger, Avi Schroeder, Pinchas Gonen, Mehdi Khaled, Neta Erez, Jörg D. Hoheisel, Carmit Levy.Melanoma miRNA trafficking controls tumour primary niche formation. Nature Cell Biology, 2016; DOI: 1038/ncb3399

Histone deacetylase inhibitors induce invasion of human melanoma cells in vitro via differential regulation of N-cadherin expression and RhoA activity

María Díaz-Núñez,
Alejandro Díez-Torre,
Olivier De Wever,
Ricardo Andrade,
Jon Arluzea,
Margarita Silió and
Juan AréchagaEmail author

BMC Cancer201616:667

DOI: 10.1186/s12885-016-2693-3

Received: 25 June 2015

Accepted: 9 August 2016

Published: 22 August 2016

PeerJ Preprints

An Integrative Computational Framework for Personalized Detection of Tumor Epitopes in Melanoma Immunotherapy

Tanushree Jaitly1, Niels Schaft1, Jan Dorrie ¨ 1, Stefanie Gross1, Beatrice Schuler-Thurner1, Olaf Wolkenhauer3, Gerold Schuler1, Leila Taher*2, Shailendra Gupta*3, and Julio Vera*1

| https://doi.org/10.7287/peerj.preprints.2385v1 | CC BY 4.0 Open Access | rec: 22 Aug 2016, publ: 22 Aug 2016

The Effect of Vector Silencing during Picornavirus Vaccination against Experimental Melanoma and Glioma

Courtney S. Malo1,2, Danielle N. Renner2,3, April M. Huseby Kelcher1,2, Fang Jin1 , Michael J. Hansen1 , Kevin D. Pavelko1 , Aaron J. Johnson1,4

PLoS ONE 11(8): e0162064. doi:10.1371/ journal.pone.0162064

Racial differences in six major subtypes of melanoma: descriptive epidemiology

Yu Wang, Yinjun Zhao and Shuangge Ma

BMC Cancer201616:691

DOI: 10.1186/s12885-016-2747-6

Received: 18 January 2016

Accepted: 24 August 2016

Published: 30 August 2016

Melanoma journal articles for July/August 2016

Coffee consumption and the risk of malignant melanoma in the Norwegian Women and Cancer (NOWAC) Study

The inhibitory effect of 7, 7”-dimethoxyagastisflavone on the metastasis of melanoma cells via the suppression of F-actin polymerization

ADAMTSL5 is upregulated in melanoma tissues in patients with idiopathic psoriasis vulgaris induced by nivolumab

Y. Nonomura, A. Otsuka, M. Ohtsuka, T. Yamamoto, R. Dummer, K. Kabashima

Complete regression of primary cutaneous malignant melanoma associated with distant lymph node metastasis: a teaching case mimicking blue nevus

Fast diagnostics of BRAF mutations in biopsies from malignant melanoma

PD-1 Antibody Monotherapy for Malignant Melanoma: A Systematic Review and Meta-Analysis

miR-579-3p controls melanoma progression and resistance to target therapy

Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model

Anorectal melanoma metastatic to the breast: a case report and review of the literature

Synergic therapy of melanoma using GNRs-MUA-PEI/siIDO2-FA through targeted gene silencing and plasmonic photothermia

Recurrent promoter mutations in melanoma are defined by an extended context-specific mutational signature

A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib

Genetic Variants of the BTNL2 Gene in Uveal Melanoma ONLINE FIRST

Melanoma differentiation associated gene 7/IL-24 exerts cytotoxic effects by altering the alternative splicing of Bcl-x pre-mRNA via the SRC/PKC? signaling axis.

Lymphatic vessels regulate immune microenvironments in human and murine melanoma

Amanda W. Lund,^1,2 Marek Wagner,^3,4 Manuel Fankhauser,² Eli S. Steinskog,³ Maria A. Broggi,² Stefani Spranger,⁵ Thomas F. Gajewski,^5,6 Kari Alitalo,⁷ Hans P. Eikesdal,^8,9 Helge Wiig,³ and Melody A. Swartz^2,10

The efficacy of anti-PD-1 agents in acral and mucosal melanoma

Disparate clinical activity of PD-1 blockade in melanoma subtypes: Know thy enemy!

Authors

Shailender Bhatia MD, Kim Margolin MD

Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-1L antibodies

Authors

Histone deacetylase inhibitors induce invasion of human melanoma cells in vitro via differential regulation of N-cadherin expression and RhoA activity

An Integrative Computational Framework for Personalized Detection of Tumor Epitopes in Melanoma Immunotherapy

The Effect of Vector Silencing during Picornavirus Vaccination against Experimental Melanoma and Glioma

Racial differences in six major subtypes of melanoma: descriptive epidemiology

Our Partners

Melanoma Research Victoria

Quick Links

Melanoma journal articles for July/August 2016

Coffee consumption and the risk of malignant melanoma in the Norwegian Women and Cancer (NOWAC) Study

The inhibitory effect of 7, 7”-dimethoxyagastisflavone on the metastasis of melanoma cells via the suppression of F-actin polymerization

ADAMTSL5 is upregulated in melanoma tissues in patients with idiopathic psoriasis vulgaris induced by nivolumab

Y. Nonomura, A. Otsuka, M. Ohtsuka, T. Yamamoto, R. Dummer, K. Kabashima

Complete regression of primary cutaneous malignant melanoma associated with distant lymph node metastasis: a teaching case mimicking blue nevus

Fast diagnostics of BRAF mutations in biopsies from malignant melanoma

PD-1 Antibody Monotherapy for Malignant Melanoma: A Systematic Review and Meta-Analysis

miR-579-3p controls melanoma progression and resistance to target therapy

Efficacy of Tumor-Targeting Salmonella A1-R on a Melanoma Patient-Derived Orthotopic Xenograft (PDOX) Nude-Mouse Model

Anorectal melanoma metastatic to the breast: a case report and review of the literature

Synergic therapy of melanoma using GNRs-MUA-PEI/siIDO2-FA through targeted gene silencing and plasmonic photothermia

Recurrent promoter mutations in melanoma are defined by an extended context-specific mutational signature

A case report of a patient with metastatic ocular melanoma who experienced a response to treatment with the BRAF inhibitor vemurafenib

­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­­Genetic Variants of the BTNL2 Gene in Uveal Melanoma ONLINE FIRST

Melanoma differentiation associated gene 7/IL-24 exerts cytotoxic effects by altering the alternative splicing of Bcl-x pre-mRNA via the SRC/PKC? signaling axis.

Lymphatic vessels regulate immune microenvironments in human and murine melanoma

Amanda W. Lund,1,2 Marek Wagner,3,4 Manuel Fankhauser,2 Eli S. Steinskog,3 Maria A. Broggi,2 Stefani Spranger,5 Thomas F. Gajewski,5,6 Kari Alitalo,7 Hans P. Eikesdal,8,9 Helge Wiig,3 and Melody A. Swartz2,10

The efficacy of anti-PD-1 agents in acral and mucosal melanoma

Disparate clinical activity of PD-1 blockade in melanoma subtypes: Know thy enemy!

Authors

Shailender Bhatia MD, Kim Margolin MD

Clinical outcomes in metastatic uveal melanoma treated with PD-1 and PD-1L antibodies

Authors

Histone deacetylase inhibitors induce invasion of human melanoma cells in vitro via differential regulation of N-cadherin expression and RhoA activity

An Integrative Computational Framework for Personalized Detection of Tumor Epitopes in Melanoma Immunotherapy

The Effect of Vector Silencing during Picornavirus Vaccination against Experimental Melanoma and Glioma

Racial differences in six major subtypes of melanoma: descriptive epidemiology

Our Partners

Melanoma Research Victoria

Quick Links

Genetic Variants of the BTNL2 Gene in Uveal Melanoma ONLINE FIRST

Amanda W. Lund,^1,2 Marek Wagner,^3,4 Manuel Fankhauser,² Eli S. Steinskog,³ Maria A. Broggi,² Stefani Spranger,⁵ Thomas F. Gajewski,^5,6 Kari Alitalo,⁷ Hans P. Eikesdal,^8,9 Helge Wiig,³ and Melody A. Swartz^2,10